Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1980 May;65(5):1222–1229. doi: 10.1172/JCI109777

Specific inhibition by prostaglandins E2 and I2 of histamine-stimulated [14C]aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells.

A H Soll
PMCID: PMC371456  PMID: 6154063

Abstract

The effects of prostaglandins E2 and I2 on accumulation of [14C]aminopyrine and the generation of cyclic AMP by fractions of dispersed canine gastric mucosal cells, enriched in their content of parietal cells, have been studied. The parietal cell content of the fractions was enriched to between 43 and 70% using an elutriator rotor. The accumulation of [14C]aminopyrine was used as the index of parietal cell response to stimulation. Prostaglandin E2 (PGE2, 0.1 nM-0.1 mM) inhibited histamine stimulated aminopyrine uptake but did not block the response to carbachol, gastrin, or dibuturyl cyclic AMP. PGE2 did, however, inhibit aminopyrine uptake stimulated by carbachol and gastrin when the response to these agents was potentiated by histamine. PGE2 (0.1 NM-0.1 mM) inhibited histamine-stimulated cyclic AMP production in a dose-dependent fashion with maximal inhibition at 1 microM PGE2. Prostacyclin also inhibited both histamine-stimulated aminopyrine accumulation and histamine-stimulated cyclic AMP production. In the absence of added histamine, PGE2 in concentrations above 1 microM and prostacyclin in concentrations above 10 microM stimulated cyclic AMP production, probably by acting on the nonparietal cells as shown in previous studies. These present data are consistent with the hypothesis that prostaglandins E2 and I2 inhibit the response of isolated parietal cells to histamine by specifically blocking histamine-stimulated cyclic AMP production.

Full text

PDF
1222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck N. P., DeRubertis F. R., Michelis M. F., Fusco R. D., Field J. B., Davis B. B. Effect of prostaglandin E 1 on certain renal actions of parathyroid hormone. J Clin Invest. 1972 Sep;51(9):2352–2358. doi: 10.1172/JCI107047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bhalla R. C., Sanborn B. M., Korenman S. G. Hormonal interactions in the uterus: inhibition of isoproterenol-induced accumulation of adenosine 3':5'-cyclic monophosphate by oxytocin and prostaglandins. Proc Natl Acad Sci U S A. 1972 Dec;69(12):3761–3764. doi: 10.1073/pnas.69.12.3761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bourne H. R., Lehrer R. I., Cline M. J., Melmon K. L. Cyclic 3',5'-adenosine monophosphate in the human lukocyte: synthesis, degradation, andeffects n neutrophil candidacidal activity. J Clin Invest. 1971 Apr;50(4):920–929. doi: 10.1172/JCI106564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Butcher R. W., Baird C. E. Effects of prostaglandins on adenosine 3',5'-monophosphate levels in fat and other tissues. J Biol Chem. 1968 Apr 25;243(8):1713–1717. [PubMed] [Google Scholar]
  5. Classen M., Koch H., Bickhardt J., Topf G., Demling L. The effect of prostaglandin E 1 on the pentagastrin-stimulated gastric secretion in man. Digestion. 1971;4(6):333–344. doi: 10.1159/000197138. [DOI] [PubMed] [Google Scholar]
  6. Glick D. M. Stimulated chloride transport by isolated parietal cells. Biochem Pharmacol. 1974 Dec 1;23(23):3283–3288. doi: 10.1016/0006-2952(74)90651-0. [DOI] [PubMed] [Google Scholar]
  7. Harper J. F., Brooker G. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res. 1975;1(4):207–218. [PubMed] [Google Scholar]
  8. Ippoliti A. F., Isenberg J. I., Maxwell V., Walsh J. H. The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients. Gastroenterology. 1976 Apr;70(4):488–491. [PubMed] [Google Scholar]
  9. Jacobson E. D., Thompson W. J. Cyclic AMP and gastric secretion: the illusive second messenger. Adv Cyclic Nucleotide Res. 1976;7:199–224. [PubMed] [Google Scholar]
  10. Johnson R. A., Lincoln F. H., Thompson J. L., Nidy E. G., Mizak S. A., Axen U. Synthesis and sterochemistry of prostacyclin and synthesis of 6-ketoprostagliandin F1alpha. J Am Chem Soc. 1977 Jun 8;99(12):4182–4184. doi: 10.1021/ja00454a060. [DOI] [PubMed] [Google Scholar]
  11. Klein I., Levey G. S. Effect of prostaglandins on guinea pig myocardial adenyl cyclase. Metabolism. 1971 Sep;20(9):890–896. doi: 10.1016/0026-0495(71)90051-5. [DOI] [PubMed] [Google Scholar]
  12. Main I. H., Whittle B. J. Investigation of the vasodilator and antisecretory role of prostaglandins in the rat gastric mucosa by use of non-steroidal anti-inflammatory drugs. Br J Pharmacol. 1975 Feb;53(2):217–224. doi: 10.1111/j.1476-5381.1975.tb07351.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Main I. H., Whittle B. J. Prostaglandin E2 and the stimulation of rat gastric acid secretion by dibutyryl cyclic 3',5'-AMP. Eur J Pharmacol. 1974 May;26(2):204–211. doi: 10.1016/0014-2999(74)90229-5. [DOI] [PubMed] [Google Scholar]
  14. Main I. H., Whittle B. J. The effects E and A prostaglandins on gastric mucosal blood flow and acid secretion in the rat. Br J Pharmacol. 1973 Nov;49(3):428–436. doi: 10.1111/j.1476-5381.1973.tb17253.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Major J. S., Scholes P. The localization of a histamine H2-receptor adenylate cyclase system in canine parietal cells and its inhibition by prostaglandins. Agents Actions. 1978 Jun;8(4):324–331. doi: 10.1007/BF01968611. [DOI] [PubMed] [Google Scholar]
  16. Mashiter K., Field J. B. Prostaglandins and the thyroid gland. Fed Proc. 1974 Jan;33(1):78–80. [PubMed] [Google Scholar]
  17. Moncada S., Salmon J. A., Vane J. R., Whittle B. J. Formation of prostacyclin and its product 6-oxo-PGF1alpha by the gastric mucosa of several species [proceedings]. J Physiol. 1978 Feb;275:4P–5P. [PubMed] [Google Scholar]
  18. Ramwell P. W., Shaw J. E. Prostaglandin inhibition of gastric secretion. J Physiol. 1968 Mar;195(2):34P–36P. [PubMed] [Google Scholar]
  19. Robert A. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Res. 1976;2:507–520. [PubMed] [Google Scholar]
  20. Robert A. Cytoprotection by prostaglandins. Gastroenterology. 1979 Oct;77(4 Pt 1):761–767. [PubMed] [Google Scholar]
  21. Simon B., Kather H. Modulation of human gastric mucosal adenylate cyclase activity by prostacyclin. Digestion. 1979;19(2):137–139. doi: 10.1159/000198335. [DOI] [PubMed] [Google Scholar]
  22. Soll A. H. The actions of secretagogues on oxygen uptake by isolated mammalian parietal cells. J Clin Invest. 1978 Feb;61(2):370–380. doi: 10.1172/JCI108947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Soll A. H. The interaction of histamine with gastrin and carbamylcholine on oxygen uptake by isolated mammalian parietal cells. J Clin Invest. 1978 Feb;61(2):381–389. doi: 10.1172/JCI108948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Soll A. H., Wollin A. Histamine and cyclic AMP in isolated canine parietal cells. Am J Physiol. 1979 Nov;237(5):E444–E450. doi: 10.1152/ajpendo.1979.237.5.E444. [DOI] [PubMed] [Google Scholar]
  25. Steiner A. L., Parker C. W., Kipnis D. M. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem. 1972 Feb 25;247(4):1106–1113. [PubMed] [Google Scholar]
  26. Tateson J. E., Moncada S., Vane J. R. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins. 1977 Mar;13(3):389–397. doi: 10.1016/0090-6980(77)90019-3. [DOI] [PubMed] [Google Scholar]
  27. Thompson W. J., Chang L. K., Rosenfeld G. C., Jacobson E. D. Activation of rat gastric mucosal adenylyl cyclase by secretory inhibitors. Gastroenterology. 1977 Feb;72(2):251–254. [PubMed] [Google Scholar]
  28. Way L., Durbin R. P. Inhibition of gastric acid secretion in vitro by prostaglandin E1. Nature. 1969 Mar 1;221(5183):874–875. doi: 10.1038/221874a0. [DOI] [PubMed] [Google Scholar]
  29. Whittle B. J. Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins. Br J Pharmacol. 1977 Jul;60(3):455–460. doi: 10.1111/j.1476-5381.1977.tb07522.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Whittle B. J. Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins. Eur J Pharmacol. 1976 Dec;40(2):233–239. doi: 10.1016/0014-2999(76)90057-1. [DOI] [PubMed] [Google Scholar]
  31. Wilson D. E., Levine R. A. The effect of prostaglandin E 1 on canine gastric acid secretion and gastric mucosal blood flow. Am J Dig Dis. 1972 Jun;17(6):527–532. doi: 10.1007/BF02231209. [DOI] [PubMed] [Google Scholar]
  32. Wolfe S. M., Shulman N. R. Adenyl cyclase activity in human platelets. Biochem Biophys Res Commun. 1969 Apr 29;35(2):265–272. doi: 10.1016/0006-291x(69)90277-0. [DOI] [PubMed] [Google Scholar]
  33. Wollin A., Code C. F., Dousa T. P. Interaction of prostaglandins and histamine with enzymes of cyclic AMP metabolism from guinea pig gastric mucosa. J Clin Invest. 1976 Jun;57(6):1548–1553. doi: 10.1172/JCI108425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wollin A., Soll A. H., Samloff I. M. Actions of histamine, secretin, and PGE2 on cyclic AMP production by isolated canine fundic mucosal cells. Am J Physiol. 1979 Nov;237(5):E437–E443. doi: 10.1152/ajpendo.1979.237.5.E437. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES